Publications by authors named "Yusuf Gunaydin"

Claim this Profile
P
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology).
Ali Inal, Hilmi Kodaz, Hatice Odabas, Ayse Ocak Duran, Mehmet Metin Seker

J Cancer Res Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.
Ayşe Demirci, Necati Alkış, Faysal Dane, Ayşe Durnalı, Ömer Kamil Yazıcı

Asia Pac J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Mahmut Gumus, Ahmet Bilici, Hatice Odabas, Bala Basak Oven Ustaalioglu, Nurten Kandemir, Yusuf Gunaydin

World J Urol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik

Balkan Med J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology).
Muhammet A Kaplan, Ulku Y Arslan, Abdurrahman Işıkdogan, Faysal Dane, Berna Oksuzoglu, Yusuf Gunaydin

Breast Care (Basel)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO).
Olcun Umit Unal, Ilhan Oztop, Serkan Menekse, Zuhat Urakci, Oktay Bozkurt, Yusuf Gunaydin

Asian Pac J Cancer Prev· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.
Onder Tonyali, Ugur Coskun, Sinemis Yuksel, Mevlude Inanc, Oznur Bal, Yusuf Gunaydin

Breast· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Olcun U Unal, Ilhan Oztop, Ozan Yazici, Tahsin Ozatli, Ali Inal

Oncol Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Olcun Umit Unal, Ilhan Oztop, Nurgul Yasar, Zuhat Urakci, Tahsin Ozatli, Yusuf Gunaydin

Thorac Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncology.
Tarkan Yetisyigit, Erkan Arpaci, Erdogan Selcuk Seber, Mehmet Kucukoner, Fatma Tugba Kos, Yusuf Gunaydin

Asian Pac J Cancer Prev· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.
Yetisyigit Tarkan, Arpaci Erkan, Erdogan Seber Selcuk, Kucukoner Mehmet, Kos F Tugba, Gunaydin Yusuf

J Cancer Res Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extremely high level of CA 19-9 in a patient with metastatic pancreatic cancer: second highest level of CA 19-9 in literature.
Muhammet Cemal Kizilarslanoglu, Ramazan Civelek, Mustafa Kemal Kilic, Mustafa Kerem, Yusuf Gunaydin

J BUON· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Mehmet Ali Nahit Sendur, Nuriye Ozdemir, Tahsin Özatlı, Ozan Yazıcı, Sercan Aksoy

Med Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab.
Onder Tonyali, Ugur Coskun, Nur Sener, Mevlude Inanc, Tulay Akman, Yusuf Gunaydin

Onkologie· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clear cell adenocarcinoma of the uterine cervix: a case report and review of the literature.
Meltem Baykara, Mustafa Benekli, Ozlem Erdem, Cagatay Taskiran, Umut Demirci, Yusuf Gunaydin

J Pediatr Hematol Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO).
Umut Demirci, Gulnihal Tufan, Bilge Aktas, Ozan Balakan, Ahmet Alacacioglu, Yusuf Gunaydin

J Cancer Res Clin Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis